Tcon stock quote
Quote for TCON | FreeRealTime.com Fundamentals by Morningstar. Data delayed 15 minutes unless otherwise indicated. Real-time ECN Stock Quotes from BATS Exchange. StockScouter ® report by Verus Analytics. Data and information is provided for informational purposes only, and is not intended for trading purposes. TCON - Tracon Pharma News - Barchart.com Van Meerten Stock Picks. Jim Van Meerten's Daily Stock Picks highlights stocks you might want to consider for your portfolio, with Jim's editorials about current events and stock market commentary. Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar. TCON Stock News - Fidelity Apr 03, 2020 · Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can …
TRACON Pharmaceuticals, Inc. (TCON) Company Bio Tracon Pharmaceuticals develops targeted therapies for cancer, wet age-related macular degeneration and fibrotic diseases. The company was founded in 2004 and is based in San Diego, California.
TCON TRACON Pharmaceuticals — Stock Price ... - StockTwits Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. TCON Stock Price, Forecast & News (TRACON Pharmaceuticals) 2 Wall Street analysts have issued 12-month price targets for TRACON Pharmaceuticals' shares. Their forecasts range from $6.00 to $6.00. On average, they anticipate TRACON Pharmaceuticals' stock price to reach $6.00 in the next year. This suggests a possible upside of 296.5% from the stock's current price.
(TCON) Company Bio. Tracon Pharmaceuticals develops targeted therapies for cancer, wet age-related macular degeneration and fibrotic diseases. The company
View the real-time TCON price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare TRACON Pharmaceuticals against related stocks people have also bought like ADXS, ONTX, VISL, and VBIV. 518 people own TRACON Pharmaceuticals on Robinhood on April 4, 2020. TCON Price Target and Analyst Ratings (TRACON Pharmaceuticals) Nov 08, 2019 · 2 Wall Street analysts have issued ratings and price targets for TRACON Pharmaceuticals in the last 12 months. Their average twelve-month price target is $6.00, suggesting that the stock has a possible upside of 252.94%. The high price target for TCON is $6.00 and the low price …
60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share.
Jan 01, 2010 · Tracon Pharmaceuticals (NASDAQ: TCON) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers TRACON Pharmaceuticals Inc., TCON Quick Chart - (NAS) TCON ... TCON - TRACON Pharmaceuticals Inc. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. 1 day 2 days 5 days 10 days ---------- 1 month 2 months 3 months 6 months YTD 1 year 2 years 3 years 4 years 5 years 1 decade All Data Basic Chart Advanced Chart TRACON Pharmaceuticals Stock Forecast: up to 2.135 USD ... Historical index on US Stock Market : E-"Should I invest in TRACON Pharmaceuticals stock?" "Should I trade "TCON" stock today?" According to our live Forecast System, TRACON Pharmaceuticals, Inc stock is an awesome long-term (1-year) investment*. "TCON" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. OTC Markets | TCON Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities.
TCON | Stock Snapshot - Fidelity
View the latest TRACON Pharmaceuticals Inc. (TCON) stock price, news, historical charts, analyst ratings and financial information from WSJ. TCON Stock Quote - TRACON Pharmaceuticals, Inc. Stock ... TCON stock quote, chart and news. Get TRACON Pharmaceuticals, Inc.'s stock price today. TCON - Tracon Pharmaceuticals Summary, Stock Quote and ...
Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. TCON Stock Price, Forecast & News (TRACON Pharmaceuticals) 2 Wall Street analysts have issued 12-month price targets for TRACON Pharmaceuticals' shares. Their forecasts range from $6.00 to $6.00. On average, they anticipate TRACON Pharmaceuticals' stock price to reach $6.00 in the next year. This suggests a possible upside of 296.5% from the stock's current price. TCON | TRACON Pharmaceuticals Inc. Profile | MarketWatch